Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Coherus BioSciences, Nasdaq: CHRS, will present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 10:50 a.m. EST / 7:50 a.m. PST. The audio presentation can be accessed on the company's investor website. Coherus specializes in commercial-stage biosimilars aimed at enhancing access to impactful therapeutics while delivering healthcare savings.
Positive
- None.
Negative
- None.
News Market Reaction – CHRS
In the trading session that priced this news, CHRS gained 2.08%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 10:50 a.m. EST / 7:50 a.m. PST.
The audio portion of the Company presentation will be available on the investors page of the Coherus BioSciences website at https://investors.coherus.com.
About Coherus BioSciences, Inc.
Coherus is a leading commercial-stage biosimilar company dedicated to expanding access to high-quality therapeutics that can have a major impact on patients’ lives and to delivering significant savings to the health care system. For additional information, please visit www.coherus.com.